SG144692A1 - Antigenic proteins of shrimp white spot syndrome virus and uses thereof - Google Patents

Antigenic proteins of shrimp white spot syndrome virus and uses thereof

Info

Publication number
SG144692A1
SG144692A1 SG200304221-5A SG2003042215A SG144692A1 SG 144692 A1 SG144692 A1 SG 144692A1 SG 2003042215 A SG2003042215 A SG 2003042215A SG 144692 A1 SG144692 A1 SG 144692A1
Authority
SG
Singapore
Prior art keywords
proteins
white spot
vaccines
spot syndrome
syndrome virus
Prior art date
Application number
SG200304221-5A
Other languages
English (en)
Inventor
Maria Vlak Justinus
Cornelia Wilhelmina Van Maria
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of SG144692A1 publication Critical patent/SG144692A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/817—Viral vaccine for fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG200304221-5A 2000-09-15 2001-09-14 Antigenic proteins of shrimp white spot syndrome virus and uses thereof SG144692A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203186 2000-09-15

Publications (1)

Publication Number Publication Date
SG144692A1 true SG144692A1 (en) 2008-08-28

Family

ID=8172024

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200304221-5A SG144692A1 (en) 2000-09-15 2001-09-14 Antigenic proteins of shrimp white spot syndrome virus and uses thereof

Country Status (10)

Country Link
US (1) US6908616B2 (ja)
EP (1) EP1366169A2 (ja)
JP (1) JP3780256B2 (ja)
CN (2) CN1651458A (ja)
AU (1) AU780206B2 (ja)
CA (1) CA2391407A1 (ja)
EC (1) ECSP024257A (ja)
MX (1) MXPA02004861A (ja)
SG (1) SG144692A1 (ja)
WO (1) WO2002022664A2 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004041005A (ja) * 2002-07-08 2004-02-12 Gen Corp:Kk 抗ホワイトスポット病組成物
WO2004025263A2 (en) * 2002-09-16 2004-03-25 Advanced Bionutrition Corporation Protein and peptide expression for passive immunity
KR100489617B1 (ko) * 2002-09-24 2005-05-17 주식회사 단바이오텍 흰반점바이러스 감염의 예방 및 치료를 위한 수용성 항체단백질 및 이를 포함한 알, 및 이들의 제조방법
BRPI0412282A (pt) * 2003-07-02 2006-09-19 Musc Found For Res Dev imunidade especìfica e não-especìfica induzida de dsrna em crustáceos e outros invertebrados, e veìculos de bioliberação para uso nestes
CN101023095B (zh) * 2004-07-09 2013-07-03 绿色生命实验室有限公司 基因工程蛋白质p40及其应用
KR100782332B1 (ko) * 2006-01-23 2007-12-06 주식회사 바이오리더스 새우 흰 반점 바이러스 항원의 표면 발현벡터 및 이에 의해형질전환된 미생물
CN1932520B (zh) * 2006-09-29 2012-03-21 武汉大学 检测对虾白斑综合症病毒的试纸条及其制备方法
CN101919873B (zh) * 2010-07-16 2011-05-04 韩健宝 抗wssv和/或tsv的核酸药物
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
WO2012058072A1 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc Method of rapidly producing vaccines for animals
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
MY153741A (en) 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
CN102174518B (zh) * 2011-01-30 2012-12-19 中国农业科学院哈尔滨兽医研究所 虾白斑综合征病毒iel启动子主要顺式作用元件及与其结合的转录因子和应用
CN105247043A (zh) * 2013-05-31 2016-01-13 英特维特国际股份有限公司 鳞片脱落疾病(sdd)致病病毒及其衍生物
CN112566932A (zh) * 2018-06-05 2021-03-26 诺沃班德畜牧业治疗公司 抗水产养殖病原体的抗体及其用途
CN110013485B (zh) * 2019-03-07 2021-07-20 汕头大学 反义核酸AMO-miR-9875在制备抗白斑综合症病毒制剂中的应用
CN110438054A (zh) * 2019-07-26 2019-11-12 上海海洋大学 vp19转基因蓝藻及其在制备防治对虾白斑综合征病毒药物中的用途
KR102330545B1 (ko) * 2019-11-18 2021-11-29 (주)애드바이오텍 새우 폐사 방지용 난황항체의 제조방법
CN112094853A (zh) * 2020-09-24 2020-12-18 扬州大学 白斑综合征病毒vp28基因、重组蛋白、多克隆抗体及制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785255A2 (en) * 1996-01-17 1997-07-23 Guang-Hsiung Kou Identification, purification and detection of WSBV (baculovirus associated with white spot syndrome)
WO2001009340A1 (en) * 1999-08-03 2001-02-08 Akzo Nobel N.V. Proteins derived from white spot syndrome virus and uses thereof
WO2001038351A2 (en) * 1999-11-24 2001-05-31 Pe Corporation (Ny) Nucleotide sequence of the shrimp white spot syndrome bacilliformvirus (wsbv), systems containing this sequence and detection kits

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834589A (en) * 1990-12-14 1998-11-10 New York University Chimeric viral receptor polypeptides
US5840535A (en) * 1997-06-02 1998-11-24 Incyte Pharmaceuticals, Inc. DNA encoding a zinc ring protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785255A2 (en) * 1996-01-17 1997-07-23 Guang-Hsiung Kou Identification, purification and detection of WSBV (baculovirus associated with white spot syndrome)
WO2001009340A1 (en) * 1999-08-03 2001-02-08 Akzo Nobel N.V. Proteins derived from white spot syndrome virus and uses thereof
WO2001038351A2 (en) * 1999-11-24 2001-05-31 Pe Corporation (Ny) Nucleotide sequence of the shrimp white spot syndrome bacilliformvirus (wsbv), systems containing this sequence and detection kits

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE WHITE SPOT SYNDROME VIRUS DNA GENOME SEQUENCE *

Also Published As

Publication number Publication date
AU2055402A (en) 2002-03-26
MXPA02004861A (es) 2003-05-23
US20040028700A1 (en) 2004-02-12
EP1366169A2 (en) 2003-12-03
CN1651458A (zh) 2005-08-10
US6908616B2 (en) 2005-06-21
AU780206B2 (en) 2005-03-10
JP3780256B2 (ja) 2006-05-31
WO2002022664A2 (en) 2002-03-21
ECSP024257A (es) 2002-08-01
CA2391407A1 (en) 2002-03-21
WO2002022664A3 (en) 2003-10-09
JP2004508818A (ja) 2004-03-25
CN1437654A (zh) 2003-08-20
CN1193094C (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ATE371373T1 (de) Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine
DK0587780T4 (da) Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
MXPA02001223A (es) Proteinas derivadas del virus de sindrome de mancha blanca y usos de las mismas.
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
HUP0102617A2 (hu) Vakcinakészítésre alkalmas Pneumococcus kolinkötőprotein-származékok
WO2001089559A3 (en) Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
WO2002013855A3 (en) Vaccines containing ribavirin and methods of use thereof
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
EP1548107A4 (en) CHROMOPROTEIN AND FLUOROPROTEINS
FR2828405B1 (fr) Vaccin anti-coronavirus
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis
CA2405084A1 (en) Neutralizing immunogenic hev polypeptides
NO20005321L (no) Vertskodet protein uttrykt i Mareks sykdoms (MDV) infiserte celler og antistoffer til dette
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
TH50271A3 (th) เพสทิไวรัสที่ไม่แผ่กระจาย
TH78124B (th) วัคซีนหน่วยย่อย ns1 ของเฟลวิไวรัส